Lec 14- Antimicrobial therapy Flashcards
1
Q
Definition
A
- An infection anywhere in the urinary tract.
- Term UTI refers to anything from asymptomatic bacteriuria to severe pyelonephritis.
- Maybe uncomplicated
- Structurally and functionally healthy urinary tract
- May be complicated
- Abnormal structurally (e.g. obstruction), functionally (e.g. incomplete bladder emptying) or neurologically, prosthetic material in situ
- All UTIs in men, pregnant women and children considered complicated
2
Q
Signs and symptoms
Upper UTI
A
- Rich blood supply meaning bacteria can enter bloo= sepsis
- Upper UTI (pyelonephritis)
- Systemically unwell
- Fever +/‐rigors
- Loin pain and tenderness
- Nausea/vomiting
- Hypotension or shock–+/‐symptoms of a lower UTI
3
Q
Signs and symptoms
Lower UTI
A
- Dysuria
- Frequency
- Suprapubic pain
- Malodorous urine
- Haematuria
4
Q
Aetiology
A
- Infection may be polymicrobial- culture report shows mixed growth
- Fungal infections, e.g. Candida Albicans
- In pts with an indwelling catheter and abx therapy

5
Q
hggyDiagnosis
A
- If severe or ≥ 3 symptoms
- TREAT
- If mild or ≤ 2 symptoms:
- Urine dipstick analysis
- Suggestive of bacterial infection:
- Urine cloudy
- Positive for nitrites and leukocyte esterase–TREAT
- Suggestive of bacterial infection:
- Urine dipstick analysis
- Send culture if:
- Pregnancy- potential damage to a fetus
- Suspected pyelonephritis
- Men
- Failed treatment or persistent symptoms
- Recurrent UTI, GU tract abnormalities, renal impairment
6
Q
Diagnosis- Don’t treatment
A
- Don’t treat:
- Asymptomatic bacteriuria in the elderly (v. common).
- Asymptomatic bacteriuria in those with indwelling urinary catheters.
- Treatment does not reduce mortality or prevent symptomatic episodes. It may, however, expose the patient to side effects and promote antibiotic resistance
7
Q
Lower Urinary Tract infection
Management
A
- Hydration
- Empiric antibiotic therapy
- Uncomplicated infection
- 1stline nitrofurantoin (low resistance rates)
- Alternative agents are trimethoprim or cefalexin
- Duration of treatment 3 days for uncomplicated infection in women, 7 days for men/ pregnant women
8
Q
Pharmacist interventions for uncomplicated UTI
A
- Promote hydration
- Analgesia –paracetamol or ibuprofen
- Promote regular review of prophylactic antibiotics to prevent UTI
- Ensure the appropriate duration of treatment for women vs men, pregnant women
- Supply using PGD in community pharmacy becoming more common
9
Q
Acute pyelonephritis
A

10
Q
Acute Pyelonephritis
Management
A
- Rehydration, analgesia, renal tract imaging
- Empiric antibiotic therapy
- broad-spectrum to cover a wider range of organisms and potential sepsis
- Need IV initially to ensure good blood levels
- Can rapidly lead to sepsis, AKI- are other medicines still appropriate
- Duration of treatment much longer (7‐14 days)
11
Q
Pharmacist’s role in pyelonephritis management
A
- Empiric antibiotic review –check culture results, previously known organisms•Check if urine samples sent
- Check if a renal ultrasound or other imaging arranged
- Analgesia, fluids
- Review concurrent medication if AKI
- Promote IV to oral switch or OPAT
- Ensure the appropriate duration of antibiotics
12
Q
Pneumonia
A
- Defined as an acute infection of the lung tissues with symptoms of acute illness
- Can be seen on CXR as an area of consolidation
- Accounts for 6.6% of deaths worldwide, leading cause of mortality in children worldwide, the mortality rate has not decreased in recent decades
- Mucus etc- clogs, prevent gas exchange= hypoxia,
- Mucus good environment for bacteria to multiply

13
Q
Main symptoms of pneumonia
A
- It can take around 6 months to fully recover
- If they are better (but not perfect) after 2 weeks then they are not to come back and get more antibiotics

14
Q
Types of pneumonia
A
- Community acquired-affects between 5‐11 per 1000 adult population; always cover Streptococcus pneumonia
- Hospital-acquired–shift to more Gram‐negative organisms due to selection pressure, e.g. Escherichia coli
- ‘Atypical’–essentially community, caused by organisms which lack a cell wall, e.g. Mycoplasma, Chlamydia
- Aspiration–inhalation of food/stomach contents; suspect with stroke/loss of consciousness- stomach acid damage oesophagus= secondary infections
- Ventilator-associated–affects ITU patients who are intubated, often multi‐resistant organisms
15
Q
Community-acquired pneumonia
A
- Is usually differentiated into mild, moderate and high severity
- Mortality ranges from <1% for mild, 5‐14% for hospitalised patients, to >30% for high severity admitted to ICU
- Caused by a range of pathogens, most commonly S. pneumonia, Haemophilus influenza, Moraxella catarrhalis
16
Q
Atypical pathogens
A
- Intracellular pathogens lack a cell wall- must target another way
- Mycoplasma pneumonia, Chlamydia pneumonia, Legionella pneumophila
- More common in younger adults than older
- Can be associated with epidemics/outbreaks
- Cannot be cultured, use urinary antigen or serology to identify
- Treated with macrolides or quinolones- (these don’t target cell wall)
17
Q
Assessing severity
A
- NICE pneumonia guidelines (2014) recommend CURB‐65 criteria:
- C= new onset confusion
- U= Urea >7 mmol/L
- R= Respiratory rate >30 breaths/min
- B= Blood pressure; systolic <90 mmHgdiastolic <60 mmHg65=
- Age >65 years old
- In primary care, can use CRB‐65 score
18
Q
Severity
A
- A score of 0‐1 (risk of death <3%): use oral antibiotics, don’t require hospital admission, amoxicillinmonotherapy
- Score = 2 (risk of death 9%): hospital admission, IV antibiotics if unable to take oral amoxicillin plus clarithromycin
- Score >3 (risk of death 15‐40%): hospital admission, consider ICU review, IV antibiotics mandatorybenzylpenicillin*plus clarithromycin
19
Q
Sepsis
A
- Ranks in the top 10 causes of death
- The mortality rate is 30% (x 5 higher than stroke)
- 150,000 hospital admissions each year in the UK
- Claims 44,000 lives annually in the UK
- Affects allages
- Occurs in:
- The community
- Long term care facilities
- Patients admitted to hospital under any and every medical speciality

20
Q
Sepsis- What is it
A
- Sepsis is characterised by a dysregulated host response to infection mediated by the immune system resulting in organ dysfunction and potentially multi‐organ failure, shock and death
21
Q
The sepsis cascade
A
- Infection (e.g. chest infection, urinary tract infection)=>
- Release of sepsis initiators –endotoxins and exotoxins from bacteria, e.g. lipopolysaccharide, TSST =>
- Release of endogenous mediators (e.g. TNFα, interleukins, nitric oxide, tissue factor) –activates coagulation mechanisms, complement system, causes endothelial damage=>
- Profound physiological effects (hypotension, tissue hypoperfusion, DIC, lactic acidosis) =>
- Organ dysfunction and septic shock
22
Q
A

23
Q
Septic Shock
A
- Sepsis with hypotension (SBP <90 mmHg) refractory to adequate volume resuscitation (boluses of up to 30 ml/kg of crystalloid fluids)
- Increased lactate >4 mmol/l (a strong predictor of mortality)

24
Q
Red flag Sepsis
A

25
Q
Treatment of sepsis
A
- Within the 1sthour:
- The Sepsis Six treatment pathway:
- Start high flow oxygen
- Take blood cultures
- Give IV antibiotics
- Give IV fluid resuscitation
- Measure lactate
- Measure hourly urine output

26
Q
Sepsis- Antibiotics
A
- Usually need broad-spectrum cover, until causative agent known
- E.g. amoxicillin, gentamicin and metronidazole
- E.g. piperacillin/tazobactam or meropenem
- If the source is clear, acceptable to be more focused, e.g. high severity CAP regimen for chest source
- Therapy should be narrowed down once source identified /organism isolated
- Cultures before antibiotics if possible, but antibiotics should not be delayed to get cultures
27
Q
Other Therapeutic Interventions‐ Treatment is complex and may include:
A
- Fluid therapy
- Vasopressors
- Inotropes
- Blood products
- Mechanical ventilation (ITU)•Surgery –e.g. incision and drainage, debridement
- Sedation (ITU)
- Analgesia
- Renal replacement (ITU)
- Stress ulcer prophylaxis (ITU)
- Imaging